Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GNMK

GenMark Diagnostics (GNMK) Stock Price, News & Analysis

GenMark Diagnostics logo

About GenMark Diagnostics Stock (NASDAQ:GNMK)

Advanced Chart

Key Stats

Today's Range
$24.04
$24.04
50-Day Range
$23.89
$24.04
52-Week Range
$8.42
$24.25
Volume
N/A
Average Volume
2.70 million shs
Market Capitalization
$1.76 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

GenMark Diagnostics, Inc., a molecular diagnostics company, engages in the developing and commercializing molecular panels based on its proprietary eSensor electrochemical detection technology. It provides ePlex instrument and respiratory pathogen panel, which integrates automated nucleic acid extraction and amplification with its eSensor technology to enable operators using ePlex system to place patient sample directly into its test cartridge and obtain results. The company also offers Blood Culture Identification Gram-Positive and Negative panel, Blood Culture Identification Fungal Pathogen panel, and ePlex Gastrointestinal Pathogen Panel. In addition, it provides XT-8 instrument, and related diagnostic and research tests, as well as certain custom manufactured reagents to support a range of molecular tests with a workstation and disposable test cartridges. Further, the company offers diagnostic tests for use with its XT-8 system that includes respiratory viral panel, cystic fibrosis genotyping test, warfarin sensitivity test, thrombophilia risk test, and hepatitis C virus genotyping test and associated custom manufactured reagents, as well as 2C19 genotyping test and eSensor SARS-CoV-2 Test. GenMark Diagnostics, Inc. sells its products through direct sales and technically specialized service organization in the United States, Europe, and internationally. The company was incorporated in 2010 and is headquartered in Carlsbad, California.

Receive GNMK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GenMark Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

GNMK Stock News Headlines

Quest Diagnostics Incorporated (DGX)
Here’s How to Claim Your Stake in Elon’s Private Company, xAI
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
Genmark Diagnos Share Chat
See More Headlines

GNMK Stock Analysis - Frequently Asked Questions

GenMark Diagnostics, Inc. (NASDAQ:GNMK) issued its earnings results on Thursday, February, 25th. The medical equipment provider reported ($0.05) earnings per share for the quarter, missing analysts' consensus estimates of ($0.01) by $0.04. The medical equipment provider had revenue of $50.08 million for the quarter, compared to analyst estimates of $50 million. GenMark Diagnostics had a negative trailing twelve-month return on equity of 39.36% and a negative net margin of 16.95%.

Based on aggregate information from My MarketBeat watchlists, some other companies that GenMark Diagnostics investors own include Advanced Micro Devices (AMD), Novavax (NVAX), Inovio Pharmaceuticals (INO), OPKO Health (OPK), Pfizer (PFE), Enphase Energy (ENPH) and Gilead Sciences (GILD).

Company Calendar

Last Earnings
2/25/2021
Today
4/26/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:GNMK
Fax
N/A
Employees
618
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-47,350,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$88.02 million
Price / Cash Flow
N/A
Book Value
$0.21 per share
Price / Book
114.48

Miscellaneous

Free Float
N/A
Market Cap
$1.76 billion
Optionable
Optionable
Beta
3.02

Social Links

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:GNMK) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners